NSEInvestor Presentation4d ago · 3 Nov 2026, 08:12 pm
Investor Presentation
Laxmi Dental Limited · LAXMIDENTL
✦ AI SummaryResults
Laxmi Dental Limited has informed the Exchange about Investor Presentation for Q2FY27 and H1FY27 Earnings Conference Call on unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Laxmi Dental Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
LAXMI_03112026201100_Investor_Presentation.pdf
View document text
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058.
Tel: 022 61437991 | Email: info@laxmidentallimited.com; co.sec@laxmidentallimited.com | Website: www.laxmidentallimited.com
CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL
Date: November 03, 2026
Listing Department Listing & Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block
BSE Scrip Code: 544339 Bandra-Kurla Complex
Bandra (E), Mumbai – 400 051
Symbol: LAXMIDENTL
Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020
Dear Sir(s)/Madam(s),
Sub: Investor Presentation on Q2FY27 and H1FY27 Earnings Conference Call of Laxmi Dental
Limited (“the Company”).
Pursuant to Regulation 30(6) read with Para A Part A Schedule III of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the
copy of Investor Presentation for Q2FY27 and H1FY27 Earnings Conference Call on unaudited
Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended
September 30, 2026.
The aforesaid shall also be available on the website of the Company i.e.
https://www.laxmidentallimited.com/for-investors.
Kindly take the above on record.
Thanking you,
For Laxmi Dental Limited
--------------------------------------------------
Suman Saha
Company Secretary and Compliance Officer
ICSI Membership Number: A33035
Encl.: As above.
LAXMI DENTAL LIMITED
Investor Presentation November 2026
Safe Harbour
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Laxmi Dental Limited (the “Company”), have
been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of
securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company
makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness,
fairness and reasonableness of the contents of this Presentation. This Presentation may not be all-inclusive and may not contain all of the
information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly
excluded.
This Presentation contains certain forward-looking statements concerning the Company’s future business prospects and business profitability,
which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward-looking
statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations
in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract
and retain highly skilled professionals, time and cost overruns on contracts, our ability to manage our international operations, government
policies and actions, regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make
any announcement in case any of these forward-looking statements become materially incorrect in the future or update any forward-looking
statements made from time to time by or on behalf of the Company.
Table of Contents
1 Slide 4 - 11
Q2 & H1 FY27 Performance & Financials Slide 4 - 11
2 Slide 12 - 29
Business Overview Slide 12 - 29
3 Slide 30 - 34
Historical Financial Statements Slide 30 - 34
4 Slide 35 - 36
Annexure Slide 35 - 36
Q2 & H1 FY27 Performance &
Financials
Management Messages
Rajesh Vrajlal Khakhar Sameer Kamlesh Merchant
Chairperson and Whole-time Director Managing Director and CEO
“We are delighted to report another strong quarter, building on the positive start we made to FY27. “During Q2FY27, the Company delivered a strong performance across segments. For the
Q2FY27 reported a highest ever quarterly revenue of INR 79.5 crore, taking H1FY27 revenue to INR quarter, our dental laboratory business grew by 22.7% year-on-year with robust growth in
154.2 crore. Growth was broad-based across our Dental Laboratory and Aligner Solutions international operations of 32.0% and healthy growth in domestic operations of 15.0%.
businesses. EBITDA and PAT margins stood at 19.2% and 12.6%, respectively. Profitability
remained healthy, supported by code dental product mix and continued operating discipline. This Aligner Solutions also delivered a strong growth of 23.5% year-on-year, driven by both Bizdent
performance reflects our innovative strategies tailored to each region and business, alongside our and Vedia, with 27.7% and 19.1% year-on-year growth, respectively. Our paediatric business,
continued focus on digitalisation and brand building. Kids-e-Dental, also continued to scale well with a year-on-year growth of 16.7%. Scanner sales
for the quarter remained muted due to inflated prices for high-end laptops. We continue to
During the quarter, our shareholders approved changes in the IPO use of proceeds, allowing INR evaluate our scanner roadmap in line with the overall market situation.
48.1 crore of unutilised proceeds to be redeployed, including INR 26.9 crore towards land and
building for a company-owned, integrated dental laboratory and aligner facility. This is expected to Our performance reflects the strength of long-standing relationships with dental partners in
enhance efficiency, strengthen cost control and support scalability. The transition will be in a India and overseas, supported by consistent execution across our sales and operations teams.
phased manner to ensure service continuity without any material impact. We continue to invest in AI-led automation to make our operations faster, more consistent and
efficient as we grow.
Looking at the bigger picture, India’s dental industry is at an early stage of a structural shift. A
highly fragmented lab market is gradually organising, dentists are adopting digital workflows, and In the Indian market we remain focused on increasing our wallet share with existing dentists
patients are increasingly choosing quality, aesthetics and trusted brands. Globally too, demand for and adding new dental partners through our hub-and-spoke strategy and digitalisation.
customised restorations has been rising, and dentists are increasingly turning to companies like Internationally, the strengthened on-ground leadership in the US, our participation at the
Laxmi Dental that deliver superior quality and faster turnaround time at a competitive cost. upcoming International Dental Show (IDS) and the India–EU Free Trade Agreement concluded
earlier this year are all expected to support our global expansion.
Over more than three decades, Laxmi Dental has built the trust, quality systems, brands and
infrastructure needed to lead this transition. We believe the decade ahead holds great promise for With continued progress in digitalisation, innovation, branding and network expansion, we
dentistry in India and globally. We continue to build our capabilities to capture this opportunity remain well positioned to deliver sustainable and profitable growth in the years ahead.”
responsibly and sustainably.”
Consolidated Statement of Profit & Loss
Consolidated P&L(INR mn) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY
Q2 FY27 Performance Highlights
Revenue from operations1 795.2 722.7 10.0% 747.0 6.5% 1,542.2 1,378.6 11.9%
• Highest-ever quarterly revenue and
[Showing first 8,000 characters — download PDF for full document]